LLY

Box IPO: High Growth Comes at a Price

Box has publicly filed for an IPO. But a quick look at the company shows a throwback to the dotcom era: all growth, no profits. More 

5 Biotech Stocks Promising Future Rewards

Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model. More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

MRK: Merck Stock a Strong Performer In the Pharma Space

Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today. More 

ARIA Stock – Ariad Shares Pop on Potential Buyout Rumors

A report that Ariad Pharmaceuticals has been approached by potential buyers sent ARIA stock up sharply. More 

The One Stock You Must Sell Now Is Eli Lilly

Eli Lilly's in a position where patents are coming off faster than new products are coming on board, a bad sign for a stock you should sell right now.... More 

5 Pharma Stocks to Buy for Big Dividends

Drugmakers aren't known for big dividends, but the pharmaceutical industry can actually offer something for income investors. More